Walk-through Videos
Join Gary Hewitt, General Superintendent, as he walks through the Acorda Therapeutics, Chelsea Manufacturing Facility Phase 2 project.
With 35 years of industry experience, Gary has worked on several life sciences projects across the Northeast. Gary and the Acorda Therapeutics project team started work at this manufacturing facility in 2018 and have a completion scheduled for October 2019. The videos below highlight critical aspects of the project.
Project at a Glance
Client
Acorda Therapeutics
Architect
CRB
Construction Cost
$92 million
Size
60,000-SF
Delivery Method
GMP
Completion Date
October 2019
For more information about the Acorda Therapeutics project, you can reach out to:
